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(YST) in a TS patient.
Case report
An 11-year-old female with TS presented with a one day history of
worsening nausea, non-bloody, non-bilious emesis, and abdominal
pain. She also had three months of worsening enuresis, constipation,
and abdominal distension. Her menses were normal with LMP of two
weeks prior to presentation.
On exam, she was afebrile, normotensive, tachycardic at 125 bpm,Tuberous sclerosis (TS) is a relatively common neurocutaneous
genetic disorder affecting 1 in 10,000 people and has a spectrum
of manifestations due to incomplete penetrance (Crino et al., 2006).
Common features include cognitive and behavioral problems, seizures,
hypomelanotic “ash-leaf” spots, facial angioﬁbromas, hamartomatous
and choristomatous tumors. Lesions commonly associated with TS
include subependymal neural tubers, renal angiomyolipomas (rAMLs)
and cardiac rhabdomyomas (Crino et al., 2006).
Gynecologic neoplasms in TS patients have also been reported
(Gyure et al., 1995). To date, there are three previous reports of ovarian
malignancies: juvenile granulosa cell tumor, epithelioid AML, and
adenocarcinoma (Gyure et al., 1995; Guo et al., 2006; Anderson et al.,onding author.
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, Department of Surgery, 3533 S.
4 4701.
ond).
. This is an open access article underand tachypnic to the mid-30's. She had facial angioﬁbromas, ash leaf
macules on the trunk and a large, non-tender mass in the suprapubic
region extending towards the right iliac fossa. Her bowel sounds were
normal and cardiac auscultation was negative for murmurs. She had
normal external female genitalia. Serum chemistry tests and beta-HCG
were normal however her serum alpha-fetoprotein (aFP) level was
280,003 ng/mL (normal: b15 ng/mL). A non-contrast computed tomo-
graphic (CT) scan revealed an 8.6 cm× 18 cm× 18 cm abdominal mass
with solid and cystic components and internal septations (Fig. 1).
Multiple enlarged left paraaortic and left common iliac lymph nodes
(measuring up to 13.0 mm × 8.5 mm) were also noted. Bilateral renal
lesions measuring 1.7 cm on the left and 1.9 cm on the right were also
noted without evidence of rupture or hemorrhage.
At laparotomy, bloody ascites and peritoneal inﬂammation were
found. The mass originated from the left ovary and was adherent to
the omentum, large bowel, small bowel, and sigmoid colon. There
were no signs of invasion into the adjacent pelvic structures and the
uterus and contralateral ovary were unremarkable. A left salpingo-
oophorectomy was performed along with peritoneal lymph node
biopsies, diaphragmatic scrapings, omentectomy, and an appendectomy.
Final pathology showed a ruptured 25 cm × 18 cm × 9 cm ovarian
mass weighing 2250 g. There were large areas of necrosis and hemor-
rhage with a mixture of solid and cystic components and no evidence
of fallopian tube involvement. Microscopically, the tumor had an
epithelial cell type appearance in a vitelline pattern with Schiller–
Duval bodies (Fig. 2). In addition, focal areas of multinucleated cells
suggestive of syncytiotrophoblast without villi were seen. Peritonealthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. Non-contrast (A) coronal (B) axial CT scan of abdomen and pelvis showing large
tumor with multiple cystic components and peritoneal inﬂammation.
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stains were strongly positive for keratin and weakly positive for CD30. A
mixed germ cell tumor with primary yolk sac and minor dysgerminoma
components was diagnosed. She was referred to oncology and given
chemotherapy according to the Children Oncology Group (COG)
AGCT0132 protocol, consisting of three cycles of cisplatin, etoposide
and bleomycin. She attained complete radiologic and biologic remission
with AFP b1 ng/mL after 3 cycles and did not require consolidation
chemotherapy.
Three months after completing chemotherapy her AFP rose to
65 ng/mL, but there was no radiologic evidence of recurrence. Her
6 month post-chemotherapy AFP was 6390 ng/mL suggesting recur-
rence, despite both CT andMRI scans being negative. A positron emission
tomography scan showed a 2 cm × 0.7 cm lesion in the left ovarian
bed for which she was given salvage chemotherapy (COG AGCTO 521
protocol) consisting of paclitaxel, ifosfamide and carboplatin. Currently,she is in complete remission 49 months post chemotherapy completion
and remains well.
Discussion
Tuberous sclerosis has a well-documented association with a
number of tumors. Tuberous sclerosis complex (TSC), speciﬁcally TSC1
or TSC2mutations or sporadic events is a potential causative oncogenic
factor in patients with TS. TSC1 and TSC2 encodes hamartin and tuberin
proteins, respectively (Crino et al., 2006). The pathophysiologic basis for
tumor formation is due to derangements in these cellular proteins
which, under normal conditions, combine to form a functional protein
complex important to negatively regulate cell growth, differentiation,
and proliferation in a wide variety of tissues (Crino et al., 2006).
Mutations in either protein give rise to abnormal protein complex
formation and function resulting in hamartomatous and choristomatous
tumors, most commonly cortical tubers, subependymal giant-cell astro-
cytomas, renal angiomyolipomas, cardiac rhabdomyomas, and renal
cell carcinomas (Napolioni & Curatolo, 2008; Nelson & Sanda, 2002).
Acute abdominal pain in 80% of TS patients is associated with renal
angiomyolipomas (Nelson & Sanda, 2002). Independent of TS-related
lesions, spontaneous rupture of rAML lesions is estimated in as many
as 15% of patients presenting with acute symptoms. This happens
even with no history of trauma, and may or may not present with
gross hematuria. Lesions greater than 4 cm have shown a greater risk
of rupture (Nelson & Sanda, 2002). While the natural history of rAML
is poorly understood, TS-associated rAMLs at diagnosis are more often
bilateral, earlier in onset, larger in diameter (average 8.9 cm) and at a
greater risk of spontaneous hemorrhage compared to the generally
solitary, sporadically occurring rAML (Nelson& Sanda, 2002). In sponta-
neous ruptured rAML, the classic triad of ﬂank pain, a palpable, tender
mass, and a gross hematuria are noted in 11% of patients (Nelson &
Sanda, 2002). Wünderlich syndrome or hemorrhagic shock may occur
in 20% of TS patients (Nelson & Sanda, 2002). This is a major consider-
ation in TS patients presenting with shock. In our patient, there was
little clinical or radiographic evidence for rAML rupture as her clinical
parameters and CT images were not consistent with a rAML or with
an ectopic focus on angiomyolipoma.
The incidence of pediatric ovarian neoplasms is 2.6 per 100,000 girls
(Dallenbach et al., 2006). Yolk sac tumors account for 1% of these
pediatric ovarian neoplasms and are more commonly noted among
patients between 18 and 25 years. We report the ﬁrst case of a patient
with TS presenting with YST. These tumors usually present with a 2–
4 week history of progressive abdominal pain and a rapidly enlarging
abdominal mass (Dallenbach et al., 2006). CT scans and magnetic
resonance imaging (MRI) are the most widely used imaging modalities
but pre-operative diagnosis remains challenging, as no studies distin-
guish YST from other ovarian masses. Our study in conjunction with
others indicates that serum AFP is elevated in tumors containing a
yolk sac component andmay serve as both a diagnostic tool andmarker
for disease progression (Dallenbach et al., 2006). Post-operative serum
AFP levels are more sensitive than radiologic studies in detecting
response to chemotherapy and disease recurrence. The median time
to recurrence is between 4 and 6 months (Dallenbach et al., 2006).
Surgical resection and combination chemotherapy are the mainstay
of therapy (Dallenbach et al., 2006). Survival rates have improved great-
ly since the introduction of platinum based chemotherapy in the late
1970's. Survival is closely related to tumor stage, surgical resection
and response to chemotherapy but other genetic factors are being
studied for prognostic value (Dallenbach et al., 2006). Importantly,
patient age and fertility sparing surgery have not been associated with
decreased survival (Low et al., 2000).
Gynecologic ovarian neoplasms in patients with TS have been
previously reported (Table 1). Our PubMed and MEDLINE search
was conducted on August 2013 and utilized the keywords “neuro-
ﬁbromatosis or neurocutaneous and yolk sac tumor or Endodermal
BA
C
Fig. 2. (A) Gross cross section of tumor showing primarily a loose sponge like appearance and more solid mucoid areas. (B) Microscopic image of tumor with a vitelline pattern (400×).
(C) Microscopic image with Schiller–Duval body (400×).
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malignancy and neoplastic neoplasm”. Three primary ovarian
neoplasms have been described previously in patients with TS
namely juvenile granulosa cell tumor, epithelioid angiomyolipoma,
and adenocarcinoma (Gyure et al., 1995; Guo et al., 2006; Anderson
et al., 2001). We report the ﬁrst case of an ovarian yolk sac tumor in a
TS patient.
While there are no large studies on TS associated gynecologic
neoplasms, there is a growing body of evidence that TS may have
more reproductive implications than previously thought. Recently, the
human papillomavirus (HPV-16) E6 oncoprotein has been shown to
cause degradation of tuberin and contribute to HPV tumorogenesis
(Lu et al., 2004). The TSC2 gene also contains an estrogen receptorTable 1
Summary of previously reported gynecologic tumors in patients with TS.
Organ Tumor type Associated abdominal
Ovary Yolk sac tumor with minor dysgerminoma
component
Bilateral renal AML
Ovary Juvenile granulosa cell tumor Contralateral JGCT thr
Ovary Epithelioid AML None reported
Ovary/uterus
Ovarian adenocarcinoma; LAM of
myometrium; microscopic ﬁnding
Endometrial adenocar
of smooth mm of the L
angiomyoma of myom
Uterus LAM Ovarian endometriom
Uterus PEComa Pecomatosis, renal AM
Uterus PEComa Pecomatosis
Uterus AML Liver AML, bilateral re
Uterus PEComa 4.0 cm myometrial ma
pelvic lymphnode LAM
Uterus PEComa Ovarian metastasis
Uterus LAM None reported
Uterus LAM of myometrium; microscopic ﬁnding Bilateral renal AML; re
Uterus LAM Intra-abdominal lymp
Uterus LAM Intra-abdominal lymp
Uterus LAM Intra-abdominal lymp
Uterus LAM in subserosal lymphatics;
microscopic ﬁnding
None reported
Key: PEComa—perivascular epithelioid cell tumor, AML—angiomyolipoma, LAM—lymphangiolebinding domain (York et al., 2005). Estrogen and progesterone
receptors have also been identiﬁed in smooth muscle cells of rAML.
The upregulation of estrogen and progesterone receptors has been
correlated with rAML growth stimulation, and non-traumatic rupture
of rAML, presumably due to the physiologic stresses of pregnancy,
and the weak, elastin poor vasculature of these tumors (Morales
et al., 2005). Interestingly, among TS patients, pulmonary lymphangi-
oleiomyomatosis almost exclusively affects female patients and is
present in up to 39% of these women (Costello et al., 2000).
In conclusion, tuberous sclerosis patients presentingwith abdominal
pain and a palpable abdominal mass are diagnostically challenging.
Although the vast majority will be diagnosed with an angiomyolipoma,
a small subset will have other malignancies such as juvenile granulosa,tumors Author PMID/reference
Present case
ee months later Guo 16516278
Anderson 11781527
cinoma; Focal sarcomatous transformation
AM in one nodule; Single small
etrium
Gyure 8598338
a Pados 235977862
L Liang 18156981
Fadare 15494070
nal AML Cil 15297212
ss; 2.5 cm uterine serosal mass; Vang 11756764
Bonetti 11406657
Longacre 8946880
troperitoneal LAM Gyure 8598338
hangiomatous cysts, renal AML Torres 7791386
hangiomatous cysts, renal AML Torres 7791386
hangiomatous cysts, renal AML Torres 7791386
Enzinger Soft tissue tumors
2nd ed. 1988
iomyomatosis PMID: PubMed identiﬁcation number.
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manuscript in conjunction with past literature, suggests abnormal
complaints and that a mass in TS patients may be associated with
alternative diagnosis which needs to be further investigated.
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